Penn Cancer Innovation
@pc3innovation
The Penn Center for Cancer Care Innovation (PC3I) works at the nexus of research and practice to create, test, and scale solutions to transform #cancercare.
ID: 1245709158755770368
http://pc3i.upenn.edu 02-04-2020 13:47:11
963 Tweet
1,1K Followers
258 Following
Congratulations to Lindsay Goldblatt & Mattia Mahmoud (Penn Medicine - Abramson Cancer Center) on being named 2024 ASCO Annual Meeting Merit Awardees! Penn Cancer Innovation Conquer Cancer, the ASCO Foundation tinyurl.com/uxcx8p9h
Congratulations to Patrick Mellors & Debanjan Pain (Penn Medicine - Abramson Cancer Center) on being named 2024 ASCO Young Investigator Awardees! Penn Cancer Innovation Conquer Cancer, the ASCO Foundation tinyurl.com/uxcx8p9h
Black women in their 20s have a 53% greater risk of #breastcancer compared to white women in the same age group. PC3I's Lola Fayanju (she/her) details the impact of racism, toxic stress, and environmental factors on cancer risk. Read more from The Philadelphia Inquirer inquirer.com/health/expert-…
Happy to share our lungPRC work assessing disparities in #lungcancer #screening follow-up via VuMedi VuMedi Oncology: vumedi.com/video/ats-2024… Penn Cancer Innovation PennPulmonaryFellowship Penn Medicine - Abramson Cancer Center UPenn CCEB ATS Early Career ATS TO Assembly
It took a village of family, friends, mentors, and an incredible team but we did it! I’m officially promoted to Associate Professor with Tenure! Penn Penn Medicine Penn Medicine - Abramson Cancer Center Penn Cancer Innovation Penn Family Medicine & Community Health
New publication in JAMA Network Open led by PC3I Associate Directors Ravi B. Parikh & Sam Takvorian found that nudges directed at both patients w/ #cancer & their clinicians increase the completion rate of Serious Illness Conversations (#SICs). pc3i.upenn.edu/patient-and-cl…
Glad to finally publish this important work with Christine Edmonds, MD Emily Conant Rebecca Hubbard Connor Grady Ritika Manik Sara Ginzberg, MD, MSHP. Equal screening mmg rates are not enough. We also need equitable diagnostic follow-up. PennSurgery Penn Medicine - Abramson Cancer Center Penn Cancer Innovation Penn Radiology
🎉Congrats to PC3I Faculty Roger Kim, MD, MSCE, DAABIP on being named a recipient of the 2024 Penn Medicine McCabe Fund Award, which supports junior faculty who initiate fresh & innovative biomedical & #surgical #research projects.
Tune in on July 24 as American Cancer Society & CAPC host a public webinar "From Early Access to Effective Scaling: The State of the Science in Innovative #PalliativeCare for #Oncology." Speakers include PC3I Associate Director Ramy Sedhom, MD & more. bit.ly/4bDvDHr
PC3I's Surbhi Grover recently attended the first The White House Africa Cancer Care Forum. Hosted by #CancerMoonshot, Department of State, & IAEA - International Atomic Energy Agency ⚛️, the forum brought together leaders & experts to work towards expanding #cancercare access & #equity across Africa. youtube.com/live/Wbn9_hjMo…
New research identifies disparities in the use of preoperative breast magnetic resonance imaging following #breastcancer diagnosis ft. Sara Ginzberg, MD, MSHP, Lola Fayanju (she/her) (@PennSurgery), Connor Grady (Dept. of Biostatistics, Epidemiology & Informatics) & Christine Edmonds, MD (Penn Radiology) Penn Cancer Innovation tinyurl.com/yc7ksx9y
🚨New publication in Journal of Clinical Oncology featuring William Schpero, Paula Chatterjee & PC3I's Samuel Takvorian: Two #Medicaid policies can interact to increase #oncology #clinicaltrial enrollment among Black and Hispanic patients. Read more from Weill Cornell Medicine⤵️ news.weill.cornell.edu/news/2024/07/m…
PC3I Associate Director Lola Fayanju (she/her) recently discussed how addressing racial disparities in #breastcancer treatment could improve #survival for people of color after diagnosis. #bcsm #healthequity Learn more from The Breast Cancer Research Foundation ⤵️ bcrf.org/blog/2024-podc…
PC3I Associate Director Charu Aggarwal, MD, MPH, FASCO discussed results from a trial evaluating the combination of CAN-2409 & valacyclovir & continued immune checkpoint inhibitors for pts w/ non small-cell #lungcancer. #NSCLC Watch the video from OncLive.com: onclive.com/view/dr-aggarw…